Osteosarcoma cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
Overview
Overview
Treatment process consisted of the local control (surgical resection, amputation which usually requires around week 10 of therapy). Additionally, patients require frequent admission during their chemotherapy treatment phase.
Osteosarcoma cost-effectiveness of therapy
Osteosarcoma cost-effectiveness of therapy
- Treatment process consisted of the local control (surgical resection, amputation which usually requires around week 10 of therapy).
- Additionally, patients require frequent admission during their chemotherapy treatment phase.[1][2]
References
References
- ↑ Luetke A, Meyers PA, Lewis I, Juergens H (May 2014). “Osteosarcoma treatment – where do we stand? A state of the art review”. Cancer Treat. Rev. 40 (4): 523–32. doi:10.1016/j.ctrv.2013.11.006. PMID 24345772.
- ↑ Anderson ME (January 2016). “Update on Survival in Osteosarcoma”. Orthop. Clin. North Am. 47 (1): 283–92. doi:10.1016/j.ocl.2015.08.022. PMID 26614941.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH